During this discussion about healthcare spending, the panelists debate whether or not current spending is proportional to the current improvements in patient outcomes.
David Calabrese, RPh, MHP, is not convinced that spending and patient outcomes are proportional, and explains that although there have been modest improvements, he feels that from a managed care standpoint factors such as the aging population are of concern.
Agreeing with Mr Calabrese, Kenneth L. Schaecher, MD, FACP, CPC, states that the debate remains that patients are getting the same value of care in relation to the dollars being spent. Dr Schaecher explains that a healthcare misalignment exists because the price of drugs keeps rising. Dr Schaecher continues by saying that pharmaceutical companies are doing their job and are bringing drugs to the market to treat conditions; however, the prices are rising because of the financial demands of their investors.
Yehuda Handelsman, MD, FACP, FACE, FNLA, concludes that issues remain, and feels that a 2-tier system may become necessary in this country to help preserve medical care.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More